MONTGOMERY, Ala. – Cue the “Pomp and Circumstance”: Auburn University at Montgomery will award more than 400 undergraduate and graduate degrees during two commencement ceremonies on Saturday, May 11, in the AUM Athletic Complex.
Carl Whatley Jr., a notable AUM alumnus who has built an impressive career in the pharmaceutical industry, will speak at the ceremonies. Whatley is currently the chief executive officer of Cendalor Life Science Ventures,which seeks to identify and invest in companies developing niche pharmaceutical products for the U.S. market.
Whatley graduated from AUM in 1983, by which time he had already begun a career in pharmaceuticals at Wyeth Laboratories. He worked with Wyeth until he founded ProEthic Pharmaceuticals in 2001. After ProEthic had grown to a $40 million company, Whatley sold it to the Kowa Company Limited. In 2009, he retired as chairman and CEO of Kowa Pharmaceuticals.